Jason Kindrachuk
Cited by
Cited by
Virology, transmission, and pathogenesis of SARS-CoV-2
M Cevik, K Kuppalli, J Kindrachuk, M Peiris
bmj 371, 2020
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection
J Dyall, CM Coleman, T Venkataraman, MR Holbrook, J Kindrachuk, ...
Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014
The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides
G Gao, D Lange, K Hilpert, J Kindrachuk, Y Zou, JTJ Cheng, ...
Biomaterials 32 (16), 3899-3909, 2011
Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis
J Kindrachuk, B Ork, S Mazur, MR Holbrook, MB Frieman, D Traynor, ...
Antimicrobial agents and chemotherapy 59 (2), 1088-1099, 2015
Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections
M Kazemzadeh-Narbat, J Kindrachuk, K Duan, H Jenssen, REW Hancock, ...
Biomaterials 31 (36), 9519-9526, 2010
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
R Ralph, J Lew, T Zeng, M Francis, B Xue, M Roux, AT Ostadgavahi, ...
The Journal of Infection in Developing Countries 14 (01), 3-17, 2020
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
J Dyall, E Postnikova, H Zhou, J Kindrachuk, RF Johnson, GG Olinger Jr, ...
Journal of general virology 95 (3), 571-577, 2014
Screening and characterization of surface-tethered cationic peptides for antimicrobial activity
K Hilpert, M Elliott, H Jenssen, J Kindrachuk, CD Fjell, J Körner, ...
Chemistry & biology 16 (1), 58-69, 2009
Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment
A Nijnik, L Madera, S Ma, M Waldbrook, MR Elliott, DM Easton, ML Mayer, ...
The Journal of Immunology 184 (5), 2539-2550, 2010
Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies
J Dyall, R Gross, J Kindrachuk, RF Johnson, GG Olinger Jr, LE Hensley, ...
Drugs 77 (18), 1935-1966, 2017
Intracellular receptor for human host defense peptide LL-37 in monocytes
N Mookherjee, DND Lippert, P Hamill, R Falsafi, A Nijnik, J Kindrachuk, ...
The Journal of Immunology 183 (4), 2688-2696, 2009
A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918–1919
ME Nickol, J Kindrachuk
BMC infectious diseases 19, 1-10, 2019
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
K Escandón, AL Rasmussen, II Bogoch, EJ Murray, K Escandón, ...
BMC infectious diseases 21 (1), 1-47, 2021
Structural studies of a peptide with immune modulating and direct antimicrobial activity
M Wieczorek, H Jenssen, J Kindrachuk, WRP Scott, M Elliott, K Hilpert, ...
Chemistry & biology 17 (9), 970-980, 2010
Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli
B Bommarius, H Jenssen, M Elliott, J Kindrachuk, M Pasupuleti, H Gieren, ...
Peptides 31 (11), 1957-1965, 2010
Innate defense regulator peptide 1018 in wound healing and wound infection
L Steinstraesser, T Hirsch, M Schulte, M Kueckelhaus, F Jacobsen, ...
Public Library of Science 7 (8), e39373, 2012
Antibacterial surfaces based on polymer brushes: investigation on the influence of brush properties on antimicrobial peptide immobilization and antimicrobial activity
G Gao, K Yu, J Kindrachuk, DE Brooks, REW Hancock, JN Kizhakkedathu
Biomacromolecules 12 (10), 3715-3727, 2011
Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory
J Kindrachuk, H Jenssen, M Elliott, A Nijnik, L Magrangeas-Janot, ...
Innate immunity 19 (3), 315-327, 2013
Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria
AH Achtman, S Pilat, CW Law, DJ Lynn, L Janot, ML Mayer, S Ma, ...
Science Translational Medicine 4 (135), 135ra64-135ra64, 2012
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity
J Kindrachuk, H Jenssen, M Elliott, R Townsend, A Nijnik, SF Lee, ...
Vaccine 27 (34), 4662-4671, 2009
The system can't perform the operation now. Try again later.
Articles 1–20